Can Linzess (linaclotide) cause fatigue and hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Linzess (Linaclotide) and Its Association with Fatigue and Low Blood Pressure

Linzess (linaclotide) can cause fatigue and hypotension, particularly through its most common side effect of diarrhea, which may lead to dehydration and subsequent hypotension and fatigue. This medication works primarily in the intestinal lumen and does not have direct cardiovascular effects, but its gastrointestinal effects can indirectly impact blood pressure and energy levels.

Mechanism and Side Effects

Linzess (linaclotide) is a guanylate cyclase-C (GC-C) agonist that works in the intestinal lumen to:

  • Increase cyclic guanosine monophosphate (cGMP)
  • Stimulate chloride secretion
  • Increase luminal fluid secretion
  • Accelerate intestinal transit 1

Primary Side Effect: Diarrhea

The FDA label clearly identifies diarrhea as the most common adverse reaction:

  • Occurs in approximately 20% of patients with IBS-C compared to 3% in placebo groups
  • Severe diarrhea reported in 2% of patients taking 145 mcg and 290 mcg doses
  • Most diarrhea cases begin within the first 2 weeks of treatment 2

Connection to Hypotension and Fatigue

The FDA label specifically notes that in post-marketing experience, severe diarrhea has been associated with:

  • Dizziness
  • Syncope
  • Hypotension
  • Electrolyte abnormalities (hypokalemia and hyponatremia)
  • Cases requiring hospitalization or IV fluid administration 2

These complications from diarrhea can directly lead to fatigue through:

  1. Dehydration
  2. Electrolyte imbalances
  3. Hypotension (low blood pressure)

Risk Factors and Monitoring

Patients at higher risk for developing hypotension and fatigue with Linzess include:

  • Elderly patients
  • Those taking medications that may lower blood pressure
  • Patients with pre-existing cardiovascular conditions
  • Those with poor fluid intake
  • Patients taking diuretics

Monitoring Recommendations

For patients taking Linzess:

  • Monitor for signs of dehydration (thirst, decreased urination, dry mouth)
  • Watch for symptoms of hypotension (dizziness, lightheadedness, fatigue)
  • Check blood pressure regularly, especially when initiating therapy
  • Ensure adequate fluid intake

Management of Hypotension and Fatigue

If a patient develops hypotension or fatigue while taking Linzess:

  1. Suspend dosing and rehydrate the patient if severe diarrhea occurs 2
  2. Consider dose reduction (Linzess is available in 72 mcg, 145 mcg, and 290 mcg doses)
  3. Evaluate electrolytes, especially if symptoms are significant
  4. Ensure adequate fluid intake
  5. In severe cases, IV fluid administration may be necessary

Alternative Options

If hypotension and fatigue are problematic with Linzess, consider alternative treatments for constipation:

  • Osmotic laxatives (e.g., polyethylene glycol)
  • Stimulant laxatives when osmotic laxatives provide inadequate response 1
  • Bulk-forming agents
  • Other secretagogues with potentially different side effect profiles

Clinical Perspective

While the primary clinical trials and drug labeling do not list fatigue and hypotension as direct side effects of Linzess, they are recognized as potential consequences of the medication's most common side effect—diarrhea. The post-marketing surveillance data in the FDA label provides the strongest evidence for this association.

The risk of these side effects should be balanced against the benefits of improved bowel function in patients with chronic idiopathic constipation or irritable bowel syndrome with constipation.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.